HK Stock MarketDetailed Quotes

02696 HENLIUS

Watchlist

23.050
-0.050-0.22%

Trading Sep 10 13:31 CST

12.53BMarket Cap16.51P/E (TTM)

HENLIUS Stock Forum

Sign in to post a comment

HSI Opens Up 60 pts; LI AUTO & NIO Advance, as HENLIUS Rockets 21%

Hong Kong stocks opened higher in the morning. $Hang Seng Index (800000.HK)$opened 60 points or 0.3% higher at 18,088. $Hang Seng China Enterprises Index (800100.HK)$ opened 22 points or 0.3% higher at 6,463. $Hang Seng TECH Index (800700.HK)$ opened 11 points or 0.3% higher at 3,689.
$FOSUN PHARMA (02196.HK)$ proposed to privatise $HENLIUS (02696.HK)$ at $24.6 per share. HENLIUS opened rocketing 21.3% at $22.85, while FOSUN PHARMA opened lifting 1.2% at...

1

Investors' belief in the company's poor revenue performance is likely causing its low P/S ratio. The company's bleak revenue outlook is contributing to its low P/S. These conditions form a barrier for the share price at these levels.

Shanghai Henlius Biotech, Inc.'s (HKG:2696) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Nov 21, 2023 20:17

Shanghai Henlius Biotech's statutory profit might not fully reflect the company's underlying earning capacity due to unusual item expense. The change from loss to profit is a positive turn for the firm.

Shanghai Henlius Biotech's (HKG:2696) Solid Earnings Are Supported By Other Strong Factors

Nov 15, 2023 00:27

UOBKH: Healthcare – China (Overweight)

The research is done by the respective broker and I do not endorse any of them. Just sharing here for information and reading pleasure.
UOBKH: Healthcare – China (Overweight) - Alpha Edge Investing
$WUXI BIO (02269.HK)$ $WUXI APPTEC (02359.HK)$ $INNOVENT BIO (01801.HK)$ $VENUS MEDTECH-B (02500.HK)$ $HENLIUS (02696.HK)$ $Aier Eye Hospital Group (300015.SZ)$ $Shenzhen Mindray Bio-Medical Electronics (300760.SZ)$

Aug 30, 2022 04:23

DBS: China Healthcare Sector – Pharmaceutical Packaging

https://alphaedgeinvesting.com/2022/08/30/dbs-china-healthcare-sector-pharmaceutical-packaging/
$MICROPORT (00853.HK)$ $WEIGAO GROUP (01066.HK)$ $CSPC PHARMA (01093.HK)$ $SINOPHARM (01099.HK)$ $CR MEDICAL (01515.HK)$ $CONSUN PHARMA (01681.HK)$ $CHUNLI MEDICAL (01858.HK)$ $UNI MEDICAL (02666.HK)$ $HENLIUS (02696.HK)$ $B-Soft Co.,Ltd. (300451.SZ)$ $Guangxi LiuYao Group (603368.SH)$ $BEIGENE (06160.HK)$

Jul 1, 2022 05:58

DBS: China Biotech Sector

https://alphaedgeinvesting.com/2022/07/01/dbs-china-biotech-sector/
$BEIGENE (06160.HK)$ $CSPC PHARMA (01093.HK)$ $HENLIUS (02696.HK)$ $MICROPORT (00853.HK)$ $WEIGAO GROUP (01066.HK)$ $SINOPHARM (01099.HK)$ $CR MEDICAL (01515.HK)$ $CONSUN PHARMA (01681.HK)$ $CHUNLI MEDICAL (01858.HK)$ $UNI MEDICAL (02666.HK)$ $HENLIUS (02696.HK)$ $B-Soft Co.,Ltd. (300451.SZ)$ $Guangxi LiuYao Group (603368.SH)$ $BEIGENE (06160.HK)$

Sep 15, 2021 02:00

$HENLIUS (02696.HK)$

Translated

Share Your Profit/Loss

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

HK

Overall